PLA2G3 Antikörper (Internal Region)

Produktnummer ABIN2469549

Der Kaninchen Polyklonal anti-PLA2G3 Antikörper (ABIN2469549) detektiert spezifisch PLA2G3 in IHC. Dieser Antikörper reagiert spezifisch mit Proben aus Human, Rind (Kuh), Affe, Schwein, Gibbon und Gorilla.

Kurzübersicht für PLA2G3 Antikörper (Internal Region) (ABIN2469549)

Target: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Reaktivität: Human, Rind (Kuh), Affe, Schwein, Gibbon, Gorilla

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PLA2G3 Antikörper ist unkonjugiert

Applikation: Immunohistochemistry (IHC)

Produktdetails anti-PLA2G3 Antikörper

Bindungsspezifität: Internal Region

Spezifität: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Aufreinigung: Immunoaffinity Chromatography

Immunogen: PLA2G3 antibody was raised against a peptide located near the internal domain of PLA2G3 (Human).

Anwendungsinformationen

Applikationshinweise: PLA2G3 antibody can be used in ELISA, and immunohistochemistry starting at 10 μg/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, 0.1 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: As with all antibodies avoid freeze/thaw cycles.

Lagerung: 4 °C/-80 °C

Informationen zur Lagerung: PLA2G3 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.

Details zu PLA2G3

Target: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Andere Bezeichnung: PLA2G3

Hintergrund: Human group III secreted phospholipase A2 belongs to a superfamily of intracellular and secreted enzymes that catalyze the hydrolysis of glycerophospholipids at the sn-2 position to release fatty acids and lysophospholipids. Group III PLA2 enzymes were originally identified in invertebrates such as bees and scorpions. Human group III sPLA2 has been shown to be a calcium dependent enzyme. It consists of a central group III sPLA2 domain flanked by unique N- and C-terminal domains that are proteolytically removed in most tissues. The sPLA2 domain is sufficient for catalytic activity. SPLA2-III is preferentially expressed in the microvascular endothelium of tissues with inflammation, ischemic injury and cancer.

Gen-ID: 50487

UniProt: Q9NZ20